Staphylococcus aureus with reduced susceptibility to vancomycin.

Wijitha Weerakoon; S D Atukorala; D S Gamage; M Wijeratne

Home/Archive/PubMed

PubMed · 12971212

Staphylococcus aureus with reduced susceptibility to vancomycin.

Wijitha Weerakoon·S D Atukorala·D S Gamage·M Wijeratne

View original source ↗Export metadata ↓

Abstract

The source did not provide an abstract. Follow the original record for more information.

Explore related subjects

Blood Vessel Prosthesis Humans Male Middle Aged Prosthesis-Related Infections Staphylococcus aureus Vancomycin Resistance Case Reports Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Wijitha Weerakoon, S D Atukorala, D S Gamage, M Wijeratne. 2003. Staphylococcus aureus with reduced susceptibility to vancomycin.. https://pubmed.ncbi.nlm.nih.gov/12971212/

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2007

Regarding "InterGard silver bifurcated graft: features and results of a multicenter study".

Explore the source record for details and available documents.

Blood Vessel Prosthesis↗

PubMed2006

Leiomyosarcoma of the superior mesenteric vein: a diagnostic and therapeutic challenge.

We report here a case of a very rare entity, a leiomyosarcoma of the mesentericoportal trunk, which was initially misdiagnosed as an unresectable pancreatic cancer invading the mesenteric vein, and which was finally treated by pancreatectomy with mesentericoportal reconstruction. The pitfalls of diagnosis and modalities of resection are discussed.

Blood Vessel Prosthesis↗

PubMed2006

The evidence for cerebral protection: an analysis and summary of the literature.

It has been considered likely that the majority of cerebral ischaemic episodes following carotid artery stenting are due to cerebral embolisation. It is intuitive therefore, to attempt to prevent these presumptive emboli, whether they are comprised of air or formed elements, from reaching the brain. Various pharmacological and mechanical solutions are being used. The available literature is hampered by comparisons against historical controls of unprotected CAS with many confounding variables that may influence outcome. There is no clinical Level-I evidence to support the use of protection devices but Level-III and Level-IV evidence suggest benefit.

Blood Vessel Prosthesis↗